NEW YORK, Dec. 03, 2020 (GLOBE NEWSWIRE) -- IN8bio, Inc., a clinical-stage biotechnology company focused on developing innovative allogeneic, autologous and genetically modified gamma-delta T cell therapies for the treatment of cancers (IN8bio or the Company), today announced an upcoming presentation that provides an update of the ongoing Phase I clinical trial of their product candidate INB-100 at the 62nd American Society of Hematology Annual Meeting & Exposition (ASH), which will take place virtually from December 5 to 8, 2020. INB-100 is designed for the treatment of patients with leukemia undergoing hematopoietic stem cell transplantation with haploidentical donors.
The poster and accompanying narrated slide presentation is titled, First-in-Human Phase I Trial of Adoptive Immunotherapy with Ex Vivo Expanded and Activated gamma delta T-Cells Following Haploidentical Bone Marrow Transplantation and Post-BMT Cyclophosphamide and reviews the study design and provides a brief update on enrollment and patient status.
The company reported that, as of abstract submission, three female subjects with acute leukemia had been enrolled in the INB-100 Phase 1 trial, of whom two had been dosed, and that no treatment-related adverse events had been recorded. The trial is continuing to enroll and treat patients. The abstract for the presentation can be found at https://ash.confex.com/ash/2020/webprogram/Paper142876.html.
The poster and slide presentation are jointly authored by the scientific and physician investigators from IN8bio and The University of Kansas Cancer Center (KU Cancer Center), and will be presented by the studys Principal Investigator, Dr. Joseph McGuirk, Schutte-Speas Professor of Hematology-Oncology, Division Director of Hematological Malignancies and Cellular Therapeutics and Medical Director, Blood and Marrow Transplant at KU Cancer Center.
This preliminary data report from KU Cancer Center with our allogeneic product candidate, INB-100, demonstrates the absence of significant GvHD in these initial patients, said William Ho, Chief Executive Officer of IN8bio. This suggests that gamma delta T-cells delivered as an off-the-shelf allogeneic cell therapy may be well tolerated and have significant potential to treat patients with serious and life-threatening cancers.
Dr. McGuirk, commented, Potentially curative stem cell transplants using partially matched donors -- called haploidentical transplants have greatly expanded access to stem cell transplantation. The infusion of donor-derived gamma delta T-cells from the stem cell donor, offers the hope of diminishing this risk of relapse and curing more patients.
About IN8bioIN8bio is a clinical-stage biotechnology company focused on developing novel therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. IN8bios technology incorporates drug-resistant immunotherapy (DRI), which has been shown in preclinical studies to function in combination with therapeutic levels of chemotherapy. IN8bio is currently conducting two investigator-initiated Phase 1 clinical trials for its lead gamma-delta T cell product candidates: INB-200 for the treatment of newly diagnosed glioblastoma, which is a difficult to treat brain tumor that progresses rapidly, and INB-100 for the treatment of patients with acute leukemia undergoing hematopoietic stem cell transplantation. For more information about the Company and its programs, visit http://www.IN8bio.com.
Forward Looking StatementsCertain statements herein concerning the Companys future expectations, plans and prospects, including without limitation, the Companys current expectations regarding the curative potential of its product candidates, constitute forward-looking statements. The use of words such as may, might, will, should, expect, plan, anticipate, believe, estimate, project, intend, future, potential, or continue, the negative of these and other similar expressions are intended to identify such forward looking statements. Such statements, based as they are on the current expectations of management, inherently involve numerous risks and uncertainties, known and unknown, many of which are beyond the Companys control. Consequently, actual future results may differ materially from the anticipated results expressed in such statements. Specific risks which could cause actual results to differ materially from the Companys current expectations include: scientific, regulatory and technical developments; failure to demonstrate safety, tolerability and efficacy; final and quality controlled verification of data and the related analyses; expense and uncertainty of obtaining regulatory approval, including from the U.S. Food and Drug Administration; and the Companys reliance on third parties, including licensors and clinical research organizations. Do not place undue reliance on any forward-looking statements included herein, which speak only as of the date hereof and which the Company is under no obligation to update or revise as a result of any event, circumstances or otherwise, unless required by applicable law.
Contact:IN8bio, Inc.Kate Rochlin, Ph.D.+1 646.933.5605info@IN8bio.com
Investor Contact:Julia Balanova+ 1 646.378.2936jbalanova@soleburytrout.com
Media Contact:Ryo Imai / Robert Flamm, Ph.D.Burns McClellan, Inc.212-213-0006 ext. 315 / 364Rimai@burnsmc.com/rflamm@burnsmc.com
Go here to see the original:
IN8bio announces first-in-human Phase 1 trial Update from The University of Kansas Cancer Center using INB-100, IN8bio's Gamma Delta T-cell product...
- Kansas City MO Resources - Stem Cells: Get Facts on Uses ... [Last Updated On: August 22nd, 2014] [Originally Added On: August 22nd, 2014]
- Stem Cell History | A History of Stem Cell Research [Last Updated On: August 23rd, 2014] [Originally Added On: August 23rd, 2014]
- Midwest Stem Cell Therapy Center, University of Kansas ... [Last Updated On: September 1st, 2014] [Originally Added On: September 1st, 2014]
- Stowers Researchers Reveal Molecular Competition Drives ... [Last Updated On: September 6th, 2014] [Originally Added On: September 6th, 2014]
- Precise and programmable biological circuits [Last Updated On: October 24th, 2014] [Originally Added On: October 24th, 2014]
- Myocardial infarction and stem cells - National Center for ... [Last Updated On: October 31st, 2014] [Originally Added On: October 31st, 2014]
- Advisory Board, Midwest Stem Cell Therapy Center [Last Updated On: November 2nd, 2014] [Originally Added On: November 2nd, 2014]
- Therapeutic potential of human induced pluripotent stem ... [Last Updated On: November 5th, 2014] [Originally Added On: November 5th, 2014]
- Exploring Stem Cell Therapy for Cerebral Palsy | See the Seitz [Last Updated On: December 12th, 2014] [Originally Added On: December 12th, 2014]
- Saint Lukes Mid America Heart Institute Offers Tips & Treatments For Heart Failure Awareness Week 2015 [Last Updated On: February 10th, 2015] [Originally Added On: February 10th, 2015]
- Topeka retailer honored as 'business of the year' [Last Updated On: March 7th, 2015] [Originally Added On: March 7th, 2015]
- Stem Cells for Paralysis: First of Its Kind Study [Last Updated On: April 7th, 2015] [Originally Added On: April 7th, 2015]
- Doctors in Kansas who treat or diagnose Stem Cell Transplant [Last Updated On: August 1st, 2015] [Originally Added On: August 1st, 2015]
- Egg Stem Cells - MIT Technology Review [Last Updated On: September 27th, 2015] [Originally Added On: September 27th, 2015]
- Kansas Regenerative Medicine Center [Last Updated On: October 19th, 2015] [Originally Added On: October 19th, 2015]
- Stem Cell Therapy for Urological Issues | Kansas RMC [Last Updated On: July 29th, 2016] [Originally Added On: July 29th, 2016]
- Stem cell program - University of Kansas Medical Center [Last Updated On: August 3rd, 2016] [Originally Added On: August 3rd, 2016]
- Kansas to Build First US Stem Cell Research Center | CorCell [Last Updated On: August 3rd, 2016] [Originally Added On: August 3rd, 2016]
- Stem Cell Therapy | Kansas RMC [Last Updated On: August 3rd, 2016] [Originally Added On: August 3rd, 2016]
- Stem Cell Therapy - North Kansas City Hospital, Kansas ... [Last Updated On: October 14th, 2016] [Originally Added On: October 14th, 2016]
- Stem Cell Collection - University of Kansas Hospital [Last Updated On: October 30th, 2016] [Originally Added On: October 30th, 2016]
- International Space Station's Crew Restored to Six People - Kansas City infoZine [Last Updated On: July 30th, 2017] [Originally Added On: July 30th, 2017]
- Scientists build DNA from scratch to alter life's blueprint - Kansas City Star [Last Updated On: July 30th, 2017] [Originally Added On: July 30th, 2017]
- Regenerative Medicine Market in the US - Forecasts, Segmentation, and Opportunity Assessment by Technavio - Business Wire (press release) [Last Updated On: August 8th, 2017] [Originally Added On: August 8th, 2017]
- Join Jon Kempin, LA Galaxy Foundation and Gift of Life Marrow Registry for Kick Blood Cancer on August 13 - LA Galaxy [Last Updated On: August 12th, 2017] [Originally Added On: August 12th, 2017]
- Paralyzed after pool accident, student heads back to college - Kansas City Star [Last Updated On: August 30th, 2017] [Originally Added On: August 30th, 2017]
- About Us, Midwest Stem Cell Therapy Center - KUMC [Last Updated On: August 30th, 2017] [Originally Added On: August 30th, 2017]
- Feared Zika virus kills brain cancer stem cells, new research shows - Kansas City Star [Last Updated On: September 8th, 2017] [Originally Added On: September 8th, 2017]
- Shawnee Woman Was Among First In The World To Undergo New FDA-Approved Cancer Therapy - KCUR [Last Updated On: September 8th, 2017] [Originally Added On: September 8th, 2017]
- Regenexx Kansas City | Helping your body heal itself [Last Updated On: September 24th, 2017] [Originally Added On: September 24th, 2017]
- Future Fertility Fix? Egg-Producing Stem Cells Found in ... [Last Updated On: October 14th, 2017] [Originally Added On: October 14th, 2017]
- Stem cells or Knee surgery - Kansas Regenerative Medicine [Last Updated On: June 28th, 2018] [Originally Added On: June 28th, 2018]
- Adult Stem Cell Therapy 101, MSCTC - University of Kansas ... [Last Updated On: July 7th, 2018] [Originally Added On: July 7th, 2018]
- Stem cells relieve chronic pain in Kansas City, MO [Last Updated On: July 30th, 2018] [Originally Added On: July 30th, 2018]
- Knee Stem Cell Treatments in Kansas City | Motus Biologics [Last Updated On: August 2nd, 2018] [Originally Added On: August 2nd, 2018]
- Kansas Stem Cell Center Close To First Clinical Trial | KCUR [Last Updated On: August 27th, 2018] [Originally Added On: August 27th, 2018]
- Stem Cell Therapy in Wichita, Kansas | Joint Pain Relief ... [Last Updated On: October 6th, 2018] [Originally Added On: October 6th, 2018]
- About Stem Cell Therapy - Kansas Regenerative Medicine [Last Updated On: November 29th, 2018] [Originally Added On: November 29th, 2018]
- Hip Stem Cell Treatment | Motus Biologics in Kansas City [Last Updated On: January 23rd, 2019] [Originally Added On: January 23rd, 2019]
- Stem Cell Therapy in Kansas City- Rejuvenate KC | Stem ... [Last Updated On: April 26th, 2019] [Originally Added On: April 26th, 2019]
- Stem Cell Procedures | Motus Biologics of Kansas City [Last Updated On: September 9th, 2019] [Originally Added On: September 9th, 2019]
- Kansas Regenerative Stem Cell Seminar - Stem Cell Centers ... [Last Updated On: September 10th, 2019] [Originally Added On: September 10th, 2019]
- Infanticide: Live Organ Harvesting Commonplace in US Abortion Mills - Church Militant [Last Updated On: October 17th, 2019] [Originally Added On: October 17th, 2019]
- Trial cancer treatment in Wichita - KAKE [Last Updated On: December 2nd, 2019] [Originally Added On: December 2nd, 2019]
- FHSU partners with Be the Match for bone marrow registry event - hays Post [Last Updated On: February 20th, 2020] [Originally Added On: February 20th, 2020]
- Seeing through a forest of SCN2A gene variation - SFARI News [Last Updated On: February 20th, 2020] [Originally Added On: February 20th, 2020]
- Incysus Therapeutics Announces Name Change to IN8bio, Inc. - GlobeNewswire [Last Updated On: August 28th, 2020] [Originally Added On: August 28th, 2020]
- [Full text] Binding of the SARS-CoV-2 Spike Protein | HMER - Dove Medical Press [Last Updated On: April 15th, 2021] [Originally Added On: April 15th, 2021]
- Kelly lauds $21 billion state budget bill, vetoes $500,000 ... [Last Updated On: June 6th, 2021] [Originally Added On: June 6th, 2021]
- The controversy being created about the origins of the virus that causes COVID-19 - Frontline [Last Updated On: July 6th, 2021] [Originally Added On: July 6th, 2021]
- COVID-19 directly damages, creates scar tissue on the kidneys, study finds - WDAF FOX4 Kansas City [Last Updated On: January 5th, 2022] [Originally Added On: January 5th, 2022]
- Four researchers named recipients of the University Scholarly Achievement Award | The University of Kansas - KU Today [Last Updated On: March 25th, 2022] [Originally Added On: March 25th, 2022]
- Jayhawks shine at 2022 Capitol Graduate Research Summit | The University of Kansas - KU Today [Last Updated On: April 19th, 2022] [Originally Added On: April 19th, 2022]
- Chemical Markers That May Unlock Future Therapeutic Uses of mRNA - Lab Manager Magazine [Last Updated On: May 2nd, 2022] [Originally Added On: May 2nd, 2022]
- The Future of Parkinson Disease Therapies and the Challenges With Stem Cell Therapies - Neurology Live [Last Updated On: June 22nd, 2022] [Originally Added On: June 22nd, 2022]
- Doctors Transplant Kidneys to Children Without Need for Immune ... [Last Updated On: July 11th, 2022] [Originally Added On: July 11th, 2022]
- California is poised to phase out sales of new gas-powered cars - Kansas Public Radio [Last Updated On: August 30th, 2022] [Originally Added On: August 30th, 2022]
- Human cells in a rat's brain could shed light on autism and ADHD - Kansas Public Radio [Last Updated On: October 13th, 2022] [Originally Added On: October 13th, 2022]